홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
BCYC
#3484
Bicycle Therapeutics plc American Depositary Shares
5.0
6
USD
+1.61%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.61%
월간 변동
+4.98%
6달 변화
-35.95%
년간 변동율
-30.49%
이전 종가
4.9
8
Open
5.0
6
Bid
Ask
Low
5.0
6
High
5.0
6
양
42
마켓
주식
헬스케어
BCYC
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.09 M
29.6 M
30.02 M
37.88 M
47.71 M
50.27 M
—
Valuation ratios
Enterprise value
429.4 M
1.4 B
605.8 M
217.05 M
-171.56 M
-272.2 M
-1.3 B
Price to earnings ratio
—
-22.8
-7.89
-3.63
-4.83
-2.24
-9.02
Price to sales ratio
—
130.42
61.52
24.33
23.1
6.76
69.17
Price to cash flow ratio
—
-103.12
-10.33
-10.83
-4.95
-1.96
-9.46
Price to book ratio
—
4.41
3.29
1.77
1.03
0.8
1.3
EBITDA 비율에 대한 기업 가치
-8.18
-21.23
-4.97
-0.98
1
1.11
2.5
Profitability ratios
Return on assets %
-0.32
-0.14
-0.27
-0.3
-0.18
-0.31
-0.27
Return on equity %
-0.53
-0.19
-0.42
-0.49
-0.21
-0.36
-0.33
Return on invested capital %
-163.78
-271.48
-901.36
-1 275.56
-1 685.04
-2 598.15
-2 105.36
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-500.1
-560.98
-806.56
-704.13
-594.96
-340.38
-4 279.65
EBITDA margin %
-487.81
-548.94
-781.06
-679.86
-574.62
-331.53
-4 187.43
Net margin %
-490.95
-571.25
-779.35
-669.72
-479.18
-301.66
-3 858.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.73
12.65
6.92
8.08
13.81
11.98
47.89
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.04
0.03
0.05
0.05
0.09
0.09
Solvency ratios
Debt to assets ratio
0.09
0.09
0.11
0.08
0.04
—
—
Debt to equity ratio
0.16
0.12
0.16
0.12
0.05
—
—
Long term debt to total assets ratio
0.09
0.06
0.07
0.05
0.03
—
—
Long term debt to total equity ratio
0.15
0.09
0.11
0.08
0.04
—
—
Per share metrics
Operating cash flow per share
—
-0.59
-2.9
-1.7
-2.83
-3.6
-3.61
EBIT per share
—
-2.62
-3.93
-5.34
-3.61
-3.57
-3.57
EBITDA per share
—
-2.56
-3.81
-5.15
-3.48
-3.47
-3.47
Total debt per share
—
1.67
1.49
1.26
0.69
—
—
Cash per share
—
17.5
11.43
14.79
15.11
9.07
40.3
Net current asset value per share
—
18.3
12.45
15.79
15.95
9.86
44.5
Tangible book value per share
—
13.82
9.13
10.42
13.62
8.8
38.09
Working capital per share
—
16.85
10.66
13.83
14.8
9.03
40.73
Book value per share
—
13.82
9.13
10.42
13.62
8.8
38.09
뉴스
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift
Bicycle Therapeutics Q1 실적, 수익 예상치를 넘어
Bicycle Therapeutics earnings beat by $0.65, revenue topped estimates
Seres names Richard Kender as executive chair and interim CEO
자전거 치료제, 차세대 단계를 위한 리더십 변경 발표
Bicycle Therapeutics announces leadership changes for next phase
Oppenheimer reiterates Outperform rating on Bicycle Therapeutics stock
Bicycle Therapeutics, Citizens서 ’시장수익률 상회’로 재평가
Bicycle Therapeutics stock rating reiterated at Market Outperform by Citizens
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
바이시클 테라퓨틱스, 투루이스트 증권 "보유" 등급 제시